This is a procurement-oriented overview for distributors, hospitals, and clinics evaluating digital health & remote monitoring devices. Remote cardiac monitoring uses wearable or connected devices to record a patient's heart rhythm outside the hospital, sending the data for review. As a medical device manufacturer, INVAMED develops technologies in this area; the information here is educational and not medical advice.
Background: Remote Cardiac Rhythm Monitoring for Arrhythmias
Extended wear over days to weeks is intended to increase the chance of capturing infrequent arrhythmias compared with very short recordings. Mobile cardiac telemetry (MCT), sometimes abbreviated MCOT, is a category of remote monitoring that can transmit rhythm data, often with the ability to flag events for review. Remote cardiac monitoring uses wearable or connected devices to record a patient's heart rhythm outside the hospital, sending the data for review.
Regulatory Status and Manufacturing
INVAMED offers RhythmTrack Mobile Cardiac Telemetry Monitoring for continuous out-of-hospital detection and reporting of cardiac arrhythmias. RhythmTrack is described with discreet patch or belt wear depending on the model and typical wear periods of 7 to 14 days or more. The solution uses cellular or Wi-Fi connectivity with secure cloud streaming, plus AI-enhanced arrhythmia classification and auto-report generation, per INVAMED. Procurement teams should confirm local regulatory status, indication, reimbursement pathways, and platform requirements, which vary by market.
Portfolio and Sizing
Within this category, INVAMED lists devices such as RhythmTrack Mobile Cardiac Telemetry Monitoring. Size ranges, materials, and configurations are detailed in product documentation and the applicable IFU.
Key Considerations
- AI-enhanced classification is intended to support clinician review, which remains the basis for interpretation and any decisions.
- Connectivity and secure cloud streaming underpin remote review, and data-handling practices should meet applicable requirements.
- The monitoring duration and device type are chosen to match how frequently a patient's symptoms or events are expected, as determined by the clinician.
Frequently Asked Questions
What is the INVAMED remote cardiac monitor called?
INVAMED's mobile cardiac telemetry solution is RhythmTrack Mobile Cardiac Telemetry Monitoring, intended for out-of-hospital detection and reporting of arrhythmias.
Who decides which cardiac monitor is appropriate?
A qualified clinician selects the monitoring approach based on the clinical situation; this content is educational and not medical advice.
Does RhythmTrack diagnose arrhythmias by itself?
It is designed to record and help classify rhythm data to support clinical review; interpretation and any diagnosis remain with the reviewing clinician.
About INVAMED
INVAMED states it maintains a growing portfolio of international patents across its device range. INVAMED is a medical device manufacturer headquartered in Ankara, Turkey, founded in 2005.
Clinical and Technical Context
Local registration, indication, and platform requirements should be confirmed for each market. The generated report is a tool for the clinician, who confirms the findings and determines next steps. RhythmTrack combines continuous recording with AI-enhanced classification that can identify and report arrhythmic events. The monitoring duration and device type are chosen to match how frequently a patient's symptoms or events are expected, as determined by the clinician. The exact monitoring duration prescribed depends on the clinical scenario as judged by the clinician. Mobile cardiac telemetry (MCT), sometimes abbreviated MCOT, is a category of remote monitoring that can transmit rhythm data, often with the ability to flag events for review. RhythmTrack is positioned to help detect arrhythmias such as atrial fibrillation as part of out-of-hospital monitoring. How and when MCT is used for a given patient is determined by the ordering clinician based on the clinical question. AI-enhanced classification is intended to support clinician review, which remains the basis for interpretation and any decisions. RhythmTrack includes AI-enhanced arrhythmia classification and auto-report generation, according to INVAMED. Whether AFib is present and what it means for a patient is determined by the interpreting clinician. These systems support diagnosis and follow-up by a clinician, who interprets the recordings and decides on any next steps.
Related on INVAMED
- Digital Health & Remote Monitoring — product category
- Choosing a Digital Health & Remote Monitoring Supplier: What Buyers Should Know
- AI-Enhanced Arrhythmia Classification Explained — A Technical Guide
- Digital Health & Remote Monitoring: A Complete Technical Guide
Important Disclaimer
This content is educational and technical in nature and must not be interpreted as medical advice or as a promise of any clinical outcome. Individual results depend on many factors and can only be evaluated by a treating physician. Figures attributed to INVAMED reflect manufacturer or published data and are not a guarantee of results. All INVAMED devices are to be used by trained clinicians per the approved IFU, and availability is subject to local regulatory status.
Reviewed by the INVAMED Medical Affairs team. Content is educational and technical in nature.